Altogether, these findings revealed that novel_miR56 enhances mesGBM cell growth in vivo and that the underlying mechanism may be attributed to PRAS40 suppression and mTORC1 reactivation, which agrees with in vitro findings on the pro-survival role of novel_miR56 in GBM. This evidence concerns the gene AKT1S1 and glioblastoma.